The 2014 PDA/FDA Virus & TSE Safety Conference brings together all levels of industry and regulatory professionals to network and benefit from a program that reviews the science of product safety related to Viruses and Transmissible Spongiform Encephalopathy agents. There will be discussions on risk mitigation strategies to avoid contamination events in biomanufacturing.
The comprehensive program agenda includes presentations and panel discussions from regulatory and industry representatives from around the world. The program covers emerging virus detection methods, consider virus safety risks associated with biological reagents used during expression cell cloning, the risk associated with new cell substrates as well as bioreactor contamination risks and risk mitigation measures. The program also covers robust virus clearance methods and strategic virus clearance considerations, In addition, an update on the BSE, vCJD and sCJD risk around the globe will be presented and evolving methods for detection of CJD and vCJD will be discussed.
During the conference, PDA will host an exhibition of leading bio/pharmaceutical companies and firms with enabling technologies (e.g. filters, chromatography, testing services, etc.) who showcase new technologies and trends. There will also be numerous networking opportunities with leading experts in the field of virus and TSE safety.